Trump's Generic Drug Tariffs Could Push Up Medicine Prices

Donald Trump's plan to impose tariffs on generic drugs raises major questions about medicine prices, US manufacturing capacity and which pharmaceutical companies will benefit or suffer. Key details of the plan remain unclear, making it difficult to assess the full economic impact. Some drugmakers could gain from the move, while others — especially those reliant on imports — face potential losses.